{
    "clinical_study": {
        "@rank": "28576", 
        "arm_group": [
            {
                "arm_group_label": "control group", 
                "description": "subjects who do not show mucosal breaks in the upper GI endoscopy consistent with reflux esophagitis and do not complain of GERD symptoms"
            }, 
            {
                "arm_group_label": "GERD group", 
                "description": "subjects who have mucosal breaks in the upper GI endoscopy consistent with reflux esophagitis and/or complain of GERD symptoms"
            }
        ], 
        "biospec_descr": {
            "textblock": "During the endoscopic examination, two biopsies of the distal esophagus are taken. Biopsies\n      are taken using standard biopsy forceps from between esophagitis erosions at a fixed\n      position 3cm above the squamo-columnar junction in order to achieve sample consistency in\n      all GERD subjects."
        }, 
        "biospec_retention": "Samples With DNA", 
        "brief_summary": {
            "textblock": "Transient receptor potential vanilloid-1 (TRPV1) receptor has been implicated in the\n      mechanism of acid induced inflammation in gastroesophageal reflux disease (GERD), and its\n      expression has been demonstrated to be mediated by neurotrophic factors, such as nerve\n      growth factor (NGF) and glial derived neurotrophic factor (GDNF). We aimed to evaluate\n      TRPV1, NGF and GDNF mRNA expression level in the GERD patients and its relationship with\n      reflux symptoms."
        }, 
        "brief_title": "Nociceptors, Neurotrophic Factors and Cytokine Expression in Gastroesophageal Reflux Disease", 
        "completion_date": {
            "#text": "October 2014", 
            "@type": "Anticipated"
        }, 
        "condition": "Gastro-esophageal Reflux Disease", 
        "condition_browse": {
            "mesh_term": "Gastroesophageal Reflux"
        }, 
        "detailed_description": {
            "textblock": "All the subjects receive upper GI endoscopy and completed questionnaires about GERD symptoms\n      under the supervision of a well-trained interviewer. Subjects are excluded if there was a\n      history of gastrointestinal surgery, Barrett's esophagus, esophageal motility disorder,\n      duodenal ulcer, benign gastric ulcer or gastroduodenal cancer and if he or she had any\n      history of systemic disease requiring chronic medication (except for hypertension and\n      diabetes mellitus).\n\n      The subjects are classified into 2 groups after upper GI endoscopy and completing\n      questionnaires about GERDsymptoms ; Gastro-esophageal reflux disease (GERD) and control\n      group."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  subjects who completed upper GI endoscopy and questionnaires about GERD symptoms\n\n        Exclusion Criteria:\n\n          -  a history of gastrointestinal surgery\n\n          -  Barrett's esophagus\n\n          -  esophageal motility disorder\n\n          -  duodenal ulcer\n\n          -  benign gastric ulcer\n\n          -  gastroduodenal cancer\n\n          -  if he or she had any history of systemic disease requiring chronic medication (except\n             for hypertension and diabetes mellitus)."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years", 
            "sampling_method": "Non-Probability Sample", 
            "study_pop": {
                "textblock": "Subjects who visit SNUBH gastroenterology department mainly for evaluating the origin of\n        suspicious GERD symptoms or for screening of gastric cancer."
            }
        }, 
        "enrollment": {
            "#text": "156", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "March 23, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02114216", 
            "org_study_id": "B-1211/180-003"
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "April 21, 2014", 
        "location": {
            "contact": {
                "last_name": "Nayoung Kim"
            }, 
            "facility": {
                "address": {
                    "city": "Seongnam", 
                    "country": "Korea, Republic of", 
                    "state": "Gyeonggi-do"
                }, 
                "name": "Seoul National University Bundang Hospital"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Korea, Republic of"
        }, 
        "number_of_groups": "2", 
        "official_title": "TRPV1, NGF and GDNF Messenger Ribonucleic Acid(mRNA) Expression of the Esophageal Mucosa in the Erosive Reflux Disease With Esophageal Reflux Symptoms", 
        "overall_contact": {
            "email": "nayoungkim49@empas.com", 
            "last_name": "Nayoung Kim, M.D.", 
            "phone": "82-31-787-7008"
        }, 
        "overall_official": {
            "affiliation": "Professor", 
            "last_name": "Nayoung Kim, M.D.", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Korea: Institutional Review Board", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "May 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "TRPV1 mRNA expression of esophageal mucosa", 
            "safety_issue": "No", 
            "time_frame": "up to 24weeks"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02114216"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Seoul National University Bundang Hospital", 
            "investigator_full_name": "Nayoung Kim", 
            "investigator_title": "Professor", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": {
            "measure": "GDNF and NGF mRNA expression of esophageal mucosa", 
            "safety_issue": "No", 
            "time_frame": "up to 24weeks"
        }, 
        "source": "Seoul National University Bundang Hospital", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Seoul National University Bundang Hospital", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "October 2013", 
        "study_design": "Observational Model: Case Control, Time Perspective: Prospective", 
        "study_type": "Observational", 
        "verification_date": "April 2014"
    }
}